Skin Tech Pharma Group

Founded by Dr Philippe Deprez in 1996 and headquartered in Spain, Skin Tech is a B2B medical aesthetics group specialising in the production of hyaluronic acid-based injectables, alongside topical peelings, mesotherapy and cosmetic products. The company offers a large range of high-quality products manufactured in-house and sold under a suite of Skin Tech own brands, supported by a complementary contract manufacturing offering. Skin Tech’s products are currently sold in more than 80 countries globally.

Skin Tech operates in an attractive, fast-growing industry; the global aesthetic medicine market is valued at more than $17bn and growing at a double-digit rate per year, underpinned by positive demographic tailwinds and with high regulatory barriers to entry. Skin Tech’s product portfolio has exposure to the highest growth segments of this market across most global markets.

Visit: Skin Tech Pharma Group website